Media and Communications

Professional \ Focused \ Dedicated

Your position:Home > Company News

Sichuan Benepure Signed Cooperation Agreement with Hunan Kingti - Hand in Hand to Create Future of Plant Extract

In January 2018, Sichuan Benepure Pharmaceutical Co., Ltd. signed a cooperation agreement and sales agreement with Hunan Kingti Bio-Tech Co., Ltd.

The agreement stipulates that Sichuan Benepure will provide technical team for Hunan Kingti, instruct its production, and increase production volume and product yield. Meanwhile, we Benepure will use our own strong sales network to broaden Kingti’s sales channels. Hunan Kingti authorized Sichuan Benepure as its exclusive distributor, and is solely responsible for the sales of all products produced by Kingti, including but not limited to Hesperidin, Synephrine, and Citrus Bioflavonoids. Hunan Kingti will concentrate on the production and the sales will be handled by Sichuan Benepure.

By dispatching technicians stationed in Hunan Kingti, we will further increase the supply of our products such as Hesperidin, Synephrine, and Citrus Bioflavonoids, and at the same time, have more confidence in product quality. The cooperation between the two parties not only enriches our product supplying channels, but also meets our strategic layout of related products.

In recent years, our company has devoted great efforts in the research and development of product technology. We gains differently and greatly in plant extracts, APIs, intermediates, amino acids and derivatives, etc. In the research of Citrus series (Hesperidin, Diosmin, Hesperidin Methylchalcone, etc.), Sophora series (Quercetin, L-rhamnose, Troxerutin, etc.), we continuously improve technology and have great achievement. In the meantime, in the development project of Paclitaxel, Green Tea Extract (Catechin, Tea polyphenols), we have successfully entered the production and commercial stage.

Previous:We are willing to do some help.
Next:Awarded New Hith-Tech Enterprise